Download Booklet - Diabetes in Asia Study Group
Download Booklet - Diabetes in Asia Study Group
Download Booklet - Diabetes in Asia Study Group
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Abstract Title<br />
Free Paper<br />
prevalence, adherence to therapy, atta<strong>in</strong>ment of blood pressure (bp) targets and cost of therapy <strong>in</strong><br />
patients with coexist<strong>in</strong>g hypertension and type 2 <strong>Diabetes</strong> Mellitus (t2DM)<br />
author : Mr albert stez<strong>in</strong> sunny ,<br />
Co author : Jubb<strong>in</strong> Jagan Jacob<br />
Objective<br />
to determ<strong>in</strong>e the prevalence, adherence to therapy, atta<strong>in</strong>ment of blood pressure (bp) targets and<br />
cost of therapy <strong>in</strong> patients with coexist<strong>in</strong>g hypertension and type 2 <strong>Diabetes</strong> Mellitus (t2DM)<br />
Sett<strong>in</strong>g<br />
out patient Diabetic Cl<strong>in</strong>ic <strong>in</strong> a university affiliated teach<strong>in</strong>g hospital<br />
Methods<br />
us<strong>in</strong>g a structured questionnaire details regard<strong>in</strong>g duration and type of <strong>Diabetes</strong> Mellitus, therapy,<br />
co-morbidities, compliance and cost of therapy was ascerta<strong>in</strong>ed. blood pressure measurements<br />
on two occasions 15 m<strong>in</strong>utes apart and anthropometry was obta<strong>in</strong>ed by the <strong>in</strong>vestigator. targets<br />
for systolic and diastolic blood pressure were based on american <strong>Diabetes</strong> association (aDa)<br />
standards of care.<br />
Results<br />
hundred patients were <strong>in</strong>terviewed. sixty two percent had coexist<strong>in</strong>g hypertension. prevalence of<br />
hypertension was more <strong>in</strong> females (70% p=0.005). the body Mass <strong>in</strong>dex (bMi) among patients with<br />
coexist<strong>in</strong>g hypertension was significantly more than among those without hypertension (28.6±5.2<br />
vs 26.6±3.2 p= 0.03). Co-morbid coronary artery disease (74% vs 26% p=0.001), chronic kidney<br />
disease (64% vs 36% p=0.001) and Dyslipidemia (95% vs 35% p=0.001) was significantly more <strong>in</strong><br />
patients with coexist<strong>in</strong>g hypertension and t2DM. only 6.2% of the hypertensive patients had bp<br />
targets meet<strong>in</strong>g the systolic and diastolic goals prescribed by the aDa. Compliance to drug therapy<br />
was good <strong>in</strong> around 75% <strong>in</strong> patients with and without hypertension (77.8% vs 78.9% p=ns). Cost<br />
of therapy was 2.2 times higher <strong>in</strong> patients with coexist<strong>in</strong>g hypertension with t2DM (rs 8191 vs<br />
rs 3698 per year)<br />
Conclusions<br />
two <strong>in</strong> three patients with t2DM have coexist<strong>in</strong>g hypertension. the prevalence of hypertension<br />
is much higher <strong>in</strong> women and the obese. Despite significant co-morbidities only 6% of patients<br />
with hypertension achieved bp targets <strong>in</strong> a university affiliated Diabetic Cl<strong>in</strong>ic.<br />
38